Literature DB >> 16944045

Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Matilde Lombardero1, Sergio Vidal, Robert Hurta, Alba Román, Kalman Kovacs, Ricardo V Lloyd, Bernd W Scheithauer.   

Abstract

Both vascular endothelial growth factor (VEGF) and its receptor Flk-1 are expressed in normal pituitary cells and in the prolactin- and growth hormone-producing GH3 cell line of the rat, thus suggesting autocrine/paracrine function. Regulation of the Flk-1 receptor system in pituitary cells is poorly understood, but evidence suggests that up-regulated growth factors play a role in its expression and activation. To study the role of growth factors in this process, we examined changes in VEGF and Flk-1 expression in GH3 cells following varied exposure to betaFGF, EGF, and TGFbeta1. Immunofluorescence labelling and laser scanning cytometry were used to measure changes in VEGF and Flk-1 expression. Results showed that betaFGF, EGF and TGFbeta up-regulated the VEGF/FLK-1 receptor system. Distinct patterns of activation were detected. At 2 hours, EGF and TGFbeta caused no significant changes in VEGF and Flk-1 expression; however, betaFGF up-regulated VEGF expression in 99% of cells but only induced modest changes in Flk-1 overexpression. A similar percentage of cells overexpressed VEGF after 24-hour incubation with betaFGF, but more prominent Flk-1 overexpression was detected. At 24 hours, EGF and TGFbeta1 induced a significant increase in both VEGF and Flk-1 expression. In summary, our findings show that VEGF/Flk-1 expression in pituitary cells may be altered by different growth factors. This may affect angiogenesis and the progression of pituitary tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944045     DOI: 10.1007/s11102-006-9989-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  43 in total

1.  Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.

Authors:  N Tsuchiya; K Sato; T Akao; H Kakinuma; R Sasaki; N Shimoda; S Satoh; T Habuchi; O Ogawa; T Kato
Journal:  Tohoku J Exp Med       Date:  2001-10       Impact factor: 1.848

Review 2.  Prognostic value of vascular endothelial growth factor in breast cancer.

Authors:  G Gasparini
Journal:  Oncologist       Date:  2000

3.  Immunolocalization of vascular endothelial growth factor in the GH3 cell line.

Authors:  S Vidal; M C Oliveira; K Kovacs; B W Scheithauer; R Lloyd
Journal:  Cell Tissue Res       Date:  2000-04       Impact factor: 5.249

4.  Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.

Authors:  P Lohrer; J Gloddek; U Hopfner; M Losa; E Uhl; U Pagotto; G K Stalla; U Renner
Journal:  Neuroendocrinology       Date:  2001-08       Impact factor: 4.914

5.  Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.

Authors:  Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Ryuichi Noguchi; Daniel J Hicklin; James Huber; Toshiya Nakatani; Hirohisa Tsujinoue; Koji Yanase; Hiroo Imazu; Hiroshi Fukui
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

6.  De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

Authors:  Z von Marschall; T Cramer; M Höcker; R Burde; T Plath; M Schirner; R Heidenreich; G Breier; E O Riecken; B Wiedenmann; S Rosewicz
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

7.  Angiogenesis in pituitary adenomas and the normal pituitary gland.

Authors:  H E Turner; Z Nagy; K C Gatter; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

8.  Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.

Authors:  N Ravindranath; D Wion; P Brachet; D Djakiew
Journal:  J Androl       Date:  2001 May-Jun

Review 9.  Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

Authors:  Napoleone Ferrara
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

Review 10.  Physiological and pathological angiogenesis in the endocrine system.

Authors:  Miklós I Góth; Erika Hubina; Stefanos Raptis; György M Nagy; Béla E Tóth
Journal:  Microsc Res Tech       Date:  2003-01-01       Impact factor: 2.769

View more
  2 in total

1.  Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells.

Authors:  Hana Vakili; Yan Jin; Peter A Cattini
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

Review 2.  Molecular Network Basis of Invasive Pituitary Adenoma: A Review.

Authors:  Qi Yang; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.